Recently updated diagnostic criteria for fibromyalgia that reduce the underdiagnosis in men had not been implemented during these studies.
Your search for major depressive disorder returned 230 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).
A systematic scoping review examines the literature about the influence of sleep disorders and disturbance on pain outcomes among US veterans with chronic nonmalignant pain.
The researchers compared Google search queries for the term “insomnia” from April and May 2020 to the same months in 2017, 2018, and 2019.
This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.
Can pain intensity scores predict psychosocial outcomes longitudinally? This study examines that question.
Cerebral MRI data suggest that neurological symptoms and cognitive impairment may be common among patients with an acute TTP event.
Investigating whether serial ketamine treatments change functional connectivity between limbic structures and resting-state networks.
Exploring the risk of alcohol use disorders in patients with insomnia.
Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.
The comorbidity of depressive disorders and late-life neurodegenerative diseases including Alzheimer disease has been widely reported. This study looks into whether there is a causal relationship existing between both or, if their co-occurrence is due to confounding or common risk factors, such as aging.
Study findings present 71% of patients with new-onset super refractory status epilepticus as having good or fair outcomes at long-term follow-up.
Disease course, fatigue, self-efficacy, and diet and exercise are major determinants of unemployment for patients with MS.
Researchers performed a double-blind randomized study to investigate the efficacy of tDCS as an augmentation strategy to sertraline in the treatment of vascular depression.
This study highlights the importance of transdiagnostic approaches to psychiatry.
Serotonergic antidepressants are effective for sleep disturbances in perimenopausal and postmenopausal women even without major depressive disorder.
Patients received 40 Hz gamma tACS to provide data on the use of varying stimulation periods.
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Is there a causal relationship between depressive disorders and late-life neurodegenerative diseases? Or, is their co-occurrence due to confounding or common risk factors, such as aging?
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Increases in multiple neurologic factors likely led the increase in United States epilepsy-related mortality rates between 1999 and 2017.
In early Parkinson Disease, fatigue, excessive daytime sleepiness, and emotional apathy are predictive of increasing fatigue severity.
Most older adults with preexisting MDD showed resilience in the first two months of the COVID-19 pandemic, but they express concerns about the future.
There is no evidence supporting the causal role of disturbed sleep patterns on AD or between major depression and AD.
Higher levels of outdoor artificial light at night are associated with less favorable sleep patterns as well as mood and anxiety disorders in adolescents.
Sleep abnormalities and cognition in bipolar disorder may be related, and may affect cognition in this patient population.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Polygenic risk scores predict the progression from unipolar depression to bipolar or psychiatric disorders.